These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 12195387

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI.
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The serological response to Verocytotoxigenic Escherichia coli in patients with haemolytic uraemic syndrome.
    Chart H, Perry NT.
    Lett Appl Microbiol; 2004 Jun; 38(5):351-4. PubMed ID: 15059202
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome.
    Masri C, Proulx F, Toledano B, Clermont MJ, Mariscalco MM, Seidman EG, Carcillo J.
    Am J Kidney Dis; 2000 Oct; 36(4):687-94. PubMed ID: 11007669
    [Abstract] [Full Text] [Related]

  • 8. [Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection].
    Prado V, Cordero J, Garreaud C, Olguin H, Arellano C, Nachar CL, Misraji A, Martínez J, Tous M, Rivas M.
    Rev Med Chil; 1995 Jan; 123(1):13-22. PubMed ID: 7569441
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antibodies to lipopolysaccharide block adherence of Shiga toxin-producing Escherichia coli to human intestinal epithelial (Henle 407) cells.
    Paton AW, Voss E, Manning PA, Paton JC.
    Microb Pathog; 1998 Jan; 24(1):57-63. PubMed ID: 9466947
    [Abstract] [Full Text] [Related]

  • 13. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota.
    Smith KE, Wilker PR, Reiter PL, Hedican EB, Bender JB, Hedberg CW.
    Pediatr Infect Dis J; 2012 Jan; 31(1):37-41. PubMed ID: 21892124
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.
    Proulx F, Toledano B, Phan V, Clermont MJ, Mariscalco MM, Seidman EG.
    Pediatr Res; 2002 Dec; 52(6):928-34. PubMed ID: 12438672
    [Abstract] [Full Text] [Related]

  • 16. Systemic antibody response to diarrheagenic Escherichia coli and LPS O111, O157 and O55 in healthy Brazilian adults.
    Zapata-Quintanilla LB, Palmeira P, Tino-De-Franco M, Amaral JA, Carbonare CB, Carbonare SB.
    Scand J Immunol; 2006 Dec; 64(6):661-7. PubMed ID: 17083623
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Verocytotoxigenic Escherichia coli serologic responses in patients with hemolytic uremic syndrome.
    Goldwater PN, Bettelheim KA.
    J Infect Dis; 2002 Aug 15; 186(4):582; author reply 582-3. PubMed ID: 12195391
    [No Abstract] [Full Text] [Related]

  • 19. Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli O157 in health and disease.
    Currie CG, McCALLUM K, Poxton IR.
    J Med Microbiol; 2001 Apr 15; 50(4):345-354. PubMed ID: 11289520
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.